Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Crews KR, Hicks JK, Pui CH, Relling MV, Evans WE. Pharmacogenomics and individualized medicine: Translating science into practice. Clin Pharmacol Ther 2012; 92: 467-75. 10.1038/clpt.2012.12022948889CrewsKRHicksJKPuiCHRellingMVEvansWE.Pharmacogenomics and individualized medicine: Translating science into practiceClin Pharmacol Ther2012924677510.1038/clpt.2012.120358952622948889Open DOISearch in Google Scholar
Evans WE, Relling MV, Rodman JH, Crom WR, Boyett JM, Pui CH. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N Engl J Med 1998; 338: 499-505. 10.1056/NEJM1998021933808039468466EvansWERellingMVRodmanJHCromWRBoyettJMPuiCH.Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemiaN Engl J Med199833849950510.1056/NEJM1998021933808039468466Open DOISearch in Google Scholar
Murphy SB, Fairclough DL, Hutchison RE, Berard CW. Non-Hodgkin’s lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol 1989; 7: 186-93. 10.1200/JCO.1989.7.2.186MurphySBFaircloughDLHutchisonREBerardCW.Non-Hodgkin’s lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institutionJ Clin Oncol198971869310.1200/JCO.1989.7.2.1862915234Open DOISearch in Google Scholar
Anderson JR, Jenkin RD, Wilson JF Kjeldsberg CR, Sposto R, Chilcote RR, et al. Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin’s lymphoma: a report of CCG-551 from the Childrens Cancer Group. J Clin Oncol 1993; 11: 1024-32. 10.1200/JCO.1993.11.6.10248501488AndersonJRJenkinRDWilsonJFKjeldsbergCRSpostoRChilcoteRRLong-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin’s lymphoma: a report of CCG-551 from the Childrens Cancer GroupJ Clin Oncol19931110243210.1200/JCO.1993.11.6.10248501488Open DOISearch in Google Scholar
Shaw GM, Lammer EJ, Zhu HP, Baker MW, Neri E, Finnell RH. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 2002; 108: 1-6.10.1002/ajmg.1019511857541ShawGMLammerEJZhuHPBakerMWNeriEFinnellRH.Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifidaAm J Med Genet20021081611857541Open DOISearch in Google Scholar
Assaraf YG. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis. Drug Resist Updat 2006; 9: 227-46. 10.1016/j.drup.2006.09.00117092765AssarafYG.The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasisDrug Resist Updat200692274610.1016/j.drup.2006.09.00117092765Open DOISearch in Google Scholar
Zeng H, Chen ZS, Belinsky MG, Rea PA, Kruh GD. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res 2001; 61: 7225-32.11585759ZengHChenZSBelinskyMGReaPAKruhGD.Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transportCancer Res200161722532Search in Google Scholar
The Pharmacogenomics Knowledgebase. Pharmacogenomics. Knowledge. Implementation. [citated 2017 Feb 06]. Available from: www.pharmgkb.orgThe Pharmacogenomics KnowledgebasePharmacogenomics. Knowledge. Implementation2017 Feb 06www.pharmgkb.orgSearch in Google Scholar
Laverdiere C, Chiasson S, Costea I, Moghrabi A, Krajinovic M. Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia. Blood 2002; 100: 3832-4. 10.1182/blood.V100.10.383212411325LaverdiereCChiassonSCosteaIMoghrabiAKrajinovicM.Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemiaBlood20021003832410.1182/blood.V100.10.383212411325Open DOISearch in Google Scholar
Imanishi H, Okamura N, Yagi M, Noro Y, Moriya Y, Nakamura T, et al. Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma. J Hum Genet 2007; 52: 166-71. 10.1007/s10038-006-0096-z17180579ImanishiHOkamuraNYagiMNoroYMoriyaYNakamuraTGenetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphomaJ Hum Genet2007521667110.1007/s10038-006-0096-z17180579Open DOISearch in Google Scholar
Kishi S, Griener J, Cheng C, Das S, Cook EH, Pei D, et al. Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 2003; 21: 3084-91. 10.1200/JCO.2003.07.05612915598KishiSGrienerJChengCDasSCookEHPeiDHomocysteine, pharmacogenetics, and neurotoxicity in children with leukemiaJ Clin Oncol20032130849110.1200/JCO.2003.07.05612915598Open DOISearch in Google Scholar
Shimasaki N, Mori T, Samejima H, Sato R, Shimada H, Yahagi N, et al. Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol Oncol 2006; 28: 64-8. 10.1097/01.mph.0000198269.61948.9016462575ShimasakiNMoriTSamejimaHSatoRShimadaHYahagiNEffects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphomaJ Pediatr Hematol Oncol20062864810.1097/01.mph.0000198269.61948.9016462575Open DOISearch in Google Scholar
Faganel Kotnik B, Dolzan V, Grabnar I, Jazbec J. Relationship of the reduced folate carrier gene polymorphism G80A to methotrexate plasma concentration, toxicity, and disease outcome in childhood acute lymphoblastic leukemia. Leuk Lymphoma 2010; 51: 724-6. 10.3109/1042819100361140220141435Faganel KotnikBDolzanVGrabnarIJazbecJ.Relationship of the reduced folate carrier gene polymorphism G80A to methotrexate plasma concentration, toxicity, and disease outcome in childhood acute lymphoblastic leukemiaLeuk Lymphoma201051724610.3109/1042819100361140220141435Open DOISearch in Google Scholar
Shimasaki N, Mori T, Torii C, Sato R, Shimada H, Tanigawara Y, et al. Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol Oncol 2008; 30: 347-52. 10.1097/MPH.0b013e318165b25d18458567ShimasakiNMoriTToriiCSatoRShimadaHTanigawaraYInfluence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphomaJ Pediatr Hematol Oncol2008303475210.1097/MPH.0b013e318165b25d18458567Open DOISearch in Google Scholar
Faganel Kotnik B, Grabnar I, Bohanec Grabar P, Dolžan V, Jazbec J. Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma. Eur J Clin Pharmacol 2011; 67: 993-1006. 10.1007/s00228-011-1046-z21509569Faganel KotnikBGrabnarIBohanec GrabarPDolžanVJazbecJ.Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphomaEur J Clin Pharmacol201167993100610.1007/s00228-011-1046-z21509569Open DOISearch in Google Scholar
Huang L, Tissing WJ, de Jonge R, van Zelst BD, Pieters R. Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia. Leukemia 2008; 22: 1798-800. 10.1038/leu.2008.6618368069HuangLTissingWJde JongeRvan ZelstBDPietersR.Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemiaLeukemia200822179880010.1038/leu.2008.6618368069Open DOISearch in Google Scholar
Zgheib NK, Akra-Ismail M, Aridi C, Mahfouz R, Abboud MR, Solh H, et al. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia. Pharmacogenet Genomics 2014; 24: 387-96. 10.1097/FPC.000000000000006925007187ZgheibNKAkra-IsmailMAridiCMahfouzRAbboudMRSolhHGenetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemiaPharmacogenet Genomics2014243879610.1097/FPC.000000000000006925007187Open DOISearch in Google Scholar
Iparraguirre L, Gutierrez-Camino A, Umerez M, Martin-Guerrero I, Astigarraga I, Navajas A, et al. MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia. Pharmacogenet Genomics 2016; 26: 517-25. 10.1097/FPC.000000000000024527649261IparraguirreLGutierrez-CaminoAUmerezMMartin-GuerreroIAstigarragaINavajasAMiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemiaPharmacogenet Genomics2016265172510.1097/FPC.000000000000024527649261Open DOISearch in Google Scholar
Lopez-Lopez E, Ballesteros J, Piñan MA, Sanchez de Toledo J, Garcia de Andoin N, Garcia-Miguel P, et al. Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia. Pharmacogenet Genomics 2013; 23: 53-61. 10.1097/FPC.0b013e32835c3b2423222202Lopez-LopezEBallesterosJPiñanMASanchez de ToledoJGarcia de AndoinNGarcia-MiguelPPolymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemiaPharmacogenet Genomics201323536110.1097/FPC.0b013e32835c3b2423222202Open DOISearch in Google Scholar
Ribas G, González-Neira A, Salas A, Milne RL, Vega A, Carracedo B, et al. Evaluating HapMap SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genes. Hum Genet 2006; 118: 669-79. 10.1007/s00439-005-0094-9RibasGGonzález-NeiraASalasAMilneRLVegaACarracedoBEvaluating HapMap SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genesHum Genet20061186697910.1007/s00439-005-0094-916323010Open DOISearch in Google Scholar
Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233-7. 10.1038/ng1001-23311586306JohnsonGCEspositoLBarrattBJSmithANHewardJDi GenovaGHaplotype tagging for the identification of common disease genesNat Genet200129233710.1038/ng1001-23311586306Open DOISearch in Google Scholar
World Health Organization. Handbook for reporting results of cancer treatment. Geneva: 1979. p. 15-22.World Health OrganizationHandbook for reporting results of cancer treatmentGeneva19791522Search in Google Scholar
National Cancer Institute. Common Toxicity Criteria Version 1. [citated 2017 Feb 06]. Available from: URL: http://ctep.cancer.gov/reporting/ctc.htmlNational Cancer InstituteCommon Toxicity Criteria Version 12017 Feb 06http://ctep.cancer.gov/reporting/ctc.htmlSearch in Google Scholar
Broad Institute. HaploView software version 4.1. [citated 2017 Feb 06]. Available from: http://www.broad.mit.edu/haploview/haploview-downloadsBroad InstituteHaploView software version 4.12017 Feb 06http://www.broad.mit.edu/haploview/haploview-downloadsSearch in Google Scholar
LGC. Science for a safer world. [citated 2017 Feb 06]. Available from: http://www.kbioscience.co.ukLGCScience for a safer world2017 Feb 06http://www.kbioscience.co.ukSearch in Google Scholar
Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004; 17; 96: 434-42.WacholderSChanockSGarcia-ClosasMEl GhormliLRothmanN.Assessing the probability that a positive report is false: an approach for molecular epidemiology studiesJ Natl Cancer Inst200417964344210.1093/jnci/djh075771399315026468Search in Google Scholar
Moscow JA, Gong M, He R, Sgagias MK, Dixon KH, Anzick SL, et al. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res 1995; 55: 3790-4.7641195MoscowJAGongMHeRSgagiasMKDixonKHAnzickSLIsolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cellsCancer Res19955537904Search in Google Scholar
Whetstine JR, Gifford AJ, Witt T, Liu XY, Flatley RM, Norris M et al. Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers. Clin Cancer Res 2001; 7: 3416-22.11705857WhetstineJRGiffordAJWittTLiuXYFlatleyRMNorrisMSingle nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriersClin Cancer Res20017341622Search in Google Scholar
Aplenc R, Thompson J, Han P, La M, Zhao H, Lange B, et al. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Res 2005; 65: 2482-7. 10.1158/0008-5472.CAN-04-260615781665AplencRThompsonJHanPLaMZhaoHLangeBMethylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemiaCancer Res2005652482710.1158/0008-5472.CAN-04-260615781665Open DOISearch in Google Scholar
Kałuzna E, Strauss E, Zając-Spychała O, Gowin E, Świątek-Kościelna B, Nowak J, et al. Functional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemia. Eur J Pharmacol 2015; 769: 93-9. 10.1016/j.ejphar.2015.10.05826528799KałuznaEStraussEZając-SpychałaOGowinEŚwiątek-KościelnaBNowakJFunctional variants of gene encoding folate metabolizing enzyme and methotrexate-related toxicity in children with acute lymphoblastic leukemiaEur J Pharmacol201576993910.1016/j.ejphar.2015.10.05826528799Open DOISearch in Google Scholar
Liao QC, Li XL, Liu ST, Zhang Y, Li TY, Qiu JC. [Association between the methylenetetrahydrofolate reductase gene polymorphisms and haplotype with toxicity response of high dose methotrexate chemotherapy]. [Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2012; 33: 735-9.22968027LiaoQCLiXLLiuSTZhangYLiTYQiuJC.[Association between the methylenetetrahydrofolate reductase gene polymorphisms and haplotype with toxicity response of high dose methotrexate chemotherapy]. [Chinese]Zhonghua Liu Xing Bing Xue Za Zhi2012337359Search in Google Scholar
Meza-Espinoza JP, Peralta-Leal V, Gutierrez-Angulo M, Macias-Gomez N, Ayala-Madrigal ML, Barros-Nuñez P, et al. XRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemia. Genet Mol Res 2009; 8: 1451-8. 10.4238/vol8-4gmr68720013659Meza-EspinozaJPPeralta-LealVGutierrez-AnguloMMacias-GomezNAyala-MadrigalMLBarros-NuñezPXRCC1 polymorphisms and haplotypes in Mexican patients with acute lymphoblastic leukemiaGenet Mol Res200981451810.4238/vol8-4gmr68720013659Open DOISearch in Google Scholar
Chokkalingam AP, Bartley K, Wiemels JL, Metayer C, Barcellos LF, Hansen HM, et al. Haplotypes of DNA repair and cell cycle control genes, X-ray exposure, and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control 2011; 22: 1721-30. 10.1007/s10552-011-9848-y21987080ChokkalingamAPBartleyKWiemelsJLMetayerCBarcellosLFHansenHMHaplotypes of DNA repair and cell cycle control genes, X-ray exposure, and risk of childhood acute lymphoblastic leukemiaCancer Causes Control20112217213010.1007/s10552-011-9848-y320619221987080Open DOISearch in Google Scholar
Mosor M, Ziółkowska I, Januszkiewicz-Lewandowska D, Nowak J. Polymorphisms and haplotypes of the NBS1 gene in childhood acute leukaemia. Eur J Cancer 2008; 44: 2226-32. 10.1016/j.ejca.2008.06.02618691878MosorMZiółkowskaIJanuszkiewicz-LewandowskaDNowakJ.Polymorphisms and haplotypes of the NBS1 gene in childhood acute leukaemiaEur J Cancer20084422263210.1016/j.ejca.2008.06.02618691878Open DOISearch in Google Scholar
Semsei AF, Erdélyi DJ, Ungvári I, Kámory E, Csókay B, Andrikovics H, et al. Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia. Leuk Res 2008; 32: 1214-20. 10.1016/j.leukres.2007.12.00918243305SemseiAFErdélyiDJUngváriIKámoryECsókayBAndrikovicsHAssociation of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemiaLeuk Res20083212142010.1016/j.leukres.2007.12.00918243305Open DOISearch in Google Scholar
Pakakasama S, Sirirat T, Kanchanachumpol S, Udomsubpayakul U, Mahasirimongkol S, Kitpoka P, et al. Genetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer 2007; 48: 16-20. 10.1002/pbc.2074216435384PakakasamaSSiriratTKanchanachumpolSUdomsubpayakulUMahasirimongkolSKitpokaPGenetic polymorphisms and haplotypes of DNA repair genes in childhood acute lymphoblastic leukaemiaPediatr Blood Cancer200748162010.1002/pbc.2074216435384Open DOISearch in Google Scholar
Bohanec Grabar P, Leandro-García LJ, Inglada-Pérez L, Logar D, Rodríguez-Antona C, Dolžan V. Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients. Pharmacogenomics 2012; 13: 1583-94. 10.2217/pgs.12.15023148635Bohanec GrabarPLeandro-GarcíaLJInglada-PérezLLogarDRodríguez-AntonaCDolžan V. Genetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patientsPharmacogenomics20121315839410.2217/pgs.12.15023148635Open DOISearch in Google Scholar
Lima A, Bernardes M, Azevedo R, Monteiro J, Sousa H, Medeiros R, Seabra V. SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients. Toxicol Sci 2014; 142: 196-209. 10.1093/toxsci/kfu16225124723LimaABernardesMAzevedoRMonteiroJSousaHMedeirosRSeabraV.SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patientsToxicol Sci201414219620910.1093/toxsci/kfu16225124723Open DOISearch in Google Scholar
Williams FM, Flintoff WF. Structural organization of the human reduced folate carrier gene: evidence for 5’ heterogeneity in lymphoblast mRNA. Somat Cell Mol Genet 1998; 24: 143-56.10.1023/B:SCAM.0000007117.50428.6310226652WilliamsFMFlintoffWF.Structural organization of the human reduced folate carrier gene: evidence for 5’ heterogeneity in lymphoblast mRNASomat Cell Mol Genet19982414356Open DOISearch in Google Scholar
Whetstine JR, Flatley RM, Matherly LH. The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter. Biochem J 2002; 367: 629-40. 10.1042/BJ2002051212144527WhetstineJRFlatleyRMMatherlyLH.The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoterBiochem J20023676294010.1042/BJ20020512122293212144527Open DOISearch in Google Scholar
Trevino LR, Shimasaki N, Yang W, Panetta JC, Cheng C, Pei D, et al. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol 2009; 27: 5972-8. 10.1200/JCO.2008.20.4156TrevinoLRShimasakiNYangWPanettaJCChengCPeiDGermline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effectsJ Clin Oncol2009275972810.1200/JCO.2008.20.4156279304019901119Open DOISearch in Google Scholar
Vidan-Jeras B, Jurca B, Dolzan V, Jeras M, Breskvar K, Bohinjec M. Caucasian Slovenian normal. In: Gjertson DW, Terasaki PI, editors. HLA 1998. Lenexa: American society for histocompability and immunogenetics; 1998. p. 180-1.Vidan-JerasBJurcaBDolzanVJerasMBreskvarKBohinjecM.Caucasian Slovenian normalGjertsonDWTerasakiPIHLA1998LenexaAmerican society for histocompability and immunogenetics19981801Search in Google Scholar
